Remission Cancer Research Results

Remission, Remission: Click to Expand ⟱
Source:
Type: target
Remission of the cancer


Scientific Papers found: Click to Expand⟱
5276- 3BP,    A Translational Study 'Case Report' on the Small Molecule 'Energy Blocker' 3-Bromopyruvate (3BP) as a Potent Anticancer Agent: From Bench Side to Bedside(2012)
- Case Report, HCC, NA
Dose↓, Remission↑,
305- AgNPs,    Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer
- Case Report, HNSCC, NA
OS↑, Dose↓, BioAv↝, toxicity↓, Remission↑, other↝, other↝, other↝, Dose↝, BioAv↝,
5372- ATO,    Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- Trial, APL, NA
Remission↑, OS↑, toxicity↓,
5449- ATV,    Pleiotropic effects of statins: A focus on cancer
- NA, Var, NA
lipid-P↓, TumCG↓, Apoptosis↑, ChemoSen↑, RAS↓, HMG-CoA↓, HMGCR↓, LDL↓, toxicity↓, Risk↓, P21↑, HDAC↓, Bcl-2↓, BAX↑, BIM↑, Casp↑, cl‑PARP↑, MMP↓, ROS↑, angioG↓, TumMeta↓, PTEN↑, eff↑, OS↑, Remission↑,
2502- Bical,    Complete Response of Metastatic Androgen Receptor–Positive Breast Cancer to Bicalutamide: Case Report and Review of the Literature
- Case Report, BC, NA
Dose↝, Remission↑,
6681- DCA,    Dichloroacetate (DCA) in Cancer Care
PDK1↓, Apoptosis↑, ROS↑, lactateProd↓, Dose↝, eff↝, toxicity↓, NP/CIPN↑, Dose↝, *BioAv↑, *Half-Life↓, GSTZ1↝, Glycolysis↓, OXPHOS↑, MPT↑, Cyt‑c↑, AIF↑, Casp↑, CSCs↓, Remission↑, ChemoSen↑, RadioS↑, toxicity↑,
1877- DCA,    Non-Hodgkin′s Lymphoma Reversal with Dichloroacetate
- Case Report, lymphoma, NA
Remission↑, p‑PDKs↓, Glycolysis↓, i-Ca+2↓, toxicity↓, Dose∅,
5013- DSF,  Cu,  Z,    Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease
- vitro+vivo, Melanoma, NA - Case Report, Melanoma, NA
P-gp↓, NF-kB↓, ChemoSen↑, angioG↓, TumCG↓, TumMeta↓, Remission↑, toxicity↓, ATF2↓, CREB↓, cycA1/CCNA1↓, TumCG↓, angioG↓, Dose↝, toxicity↝,
638- EGCG,  MushCha,  MushReishi,    A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea
- Case Report, AML, NA
Remission↑,
653- EGCG,    Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL)
- Trial, CLL, NA
ALC↓, Remission↑,
652- EGCG,  VitK2,  CUR,    Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter
- Case Report, CLL, NA
Remission↑,
2501- EGCG,    A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea
- Case Report, AML, NA
OS↑, Remission↑, eff↑, Dose↝,
5494- EP,    An Overview of Subnanosecond Pulsed Electric Field Biological Effects: Toward Contactless Technologies for Cancer Treatment
- Review, Var, NA
other↝, ROS↑, Temp∅, CellMemb↑, Ca+2↑, Apoptosis↑, TumCD↑, MMP↓, necrosis↑, TumVol↓, Remission↑,
2153- Ex,    The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects
- Review, Var, NA
eff↑, BMD↑, cognitive↑, OS↑, Remission↑, eff↑,
789- GE,    Complete remission of pulmonary spindle cell carcinoma after treatment with oral germanium sesquioxide
- Case Report, SCC, NA
Remission↑,
1441- HCQ,  Chemo,    Case report: stage 4 pancreatic cancer to remission using paricalcitol and hydroxychloroquine in addition to traditional chemotherapy
- Case Report, GBM, NA
TumAuto↓, Remission↑,
1776- MEL,    Therapeutic strategies of melatonin in cancer patients: a systematic review and meta-analysis
- Review, NA, NA
Remission↑, OS↑, neuroP↑, VEGF↓, KISS1↑, TumCP↓, ChemoSideEff↓, radioP↑, Dose∅, *ROS↓, DNArepair↑, ROS↑,
1783- MEL,    The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials
- Review, Var, NA
Dose∅, Remission↑, OS↑, radioP↑,
1784- MEL,    Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials
- Review, NA, NA
Remission↑,
2490- metroC,    Durable complete response of hepatocellular carcinoma after metronomic capecitabine
- Case Report, HCC, NA
angioG↓, TumVol↓, Remission↑,
5607- NaHCO3,    Does Baking Soda Function as a Magic Bullet for Patients With Cancer? A Mini Review
- Review, Var, NA
AntiCan↑, e-pH↑, TumMeta↓, TumCI↓, TumCG↓, CD8+↑, NK cell↑, Remission↑, eff↑, ChemoSen↑, ChemoSen↓,
1494- SFN,  doxoR,    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model
- in-vivo, BC, NA - in-vitro, BC, MCF7 - in-vitro, Nor, MCF10
CardioT↓, *GSH↑, *ROS↓, *NRF2↑, NRF2∅, HDAC↓, DNMTs↓, Casp3↑, ER-α36↓, Remission↑, eff↑, ROS↑, selectivity?,
2233- SK,    Clinical trial on the effects of shikonin mixture on later stage lung cancer
- Trial, Lung, NA
TumVol↓, Remission↑, OS↑, QoL↑, Weight↑, *toxicity∅,
2485- VitC,  TACE,    High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma
- Case Report, HCC, NA
ROS↑, Dose↝, Dose↝, TumCG↓, Remission↑,
615- VitC,    High Dose IV Vitamin C and Metastatic Breast Cancer: A Case Report
- Case Report, NA, NA
OS↑, Remission↑,

Showing Research Papers: 1 to 25 of 25

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 25

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

GSTZ1↝, 1,   lipid-P↓, 1,   NRF2∅, 1,   OXPHOS↑, 1,   ROS↑, 6,  

Mitochondria & Bioenergetics(tgid=3)

AIF↑, 1,   MMP↓, 2,   MPT↑, 1,  

Core Metabolism/Glycolysis(tgid=4)

CREB↓, 1,   Glycolysis↓, 2,   HMG-CoA↓, 1,   lactateProd↓, 1,   LDL↓, 1,   PDK1↓, 1,   p‑PDKs↓, 1,  

Cell Death(tgid=5)

Apoptosis↑, 3,   ATF2↓, 1,   BAX↑, 1,   Bcl-2↓, 1,   BIM↑, 1,   Casp↑, 2,   Casp3↑, 1,   Cyt‑c↑, 1,   necrosis↑, 1,   TumCD↑, 1,  

Transcription & Epigenetics(tgid=7)

KISS1↑, 1,   other↝, 4,  

Autophagy & Lysosomes(tgid=9)

TumAuto↓, 1,  

DNA Damage & Repair(tgid=10)

DNArepair↑, 1,   DNMTs↓, 1,   cl‑PARP↑, 1,  

Cell Cycle & Senescence(tgid=11)

cycA1/CCNA1↓, 1,   P21↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

CSCs↓, 1,   HDAC↓, 2,   HMGCR↓, 1,   PTEN↑, 1,   RAS↓, 1,   TumCG↓, 5,  

Migration(tgid=13)

Ca+2↑, 1,   i-Ca+2↓, 1,   ER-α36↓, 1,   TumCI↓, 1,   TumCP↓, 1,   TumMeta↓, 3,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 4,   VEGF↓, 1,  

Barriers & Transport(tgid=15)

CellMemb↑, 1,   P-gp↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

NF-kB↓, 1,   NK cell↑, 1,  

Cellular Microenvironment(tgid=17)

e-pH↑, 1,   Temp∅, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↝, 2,   ChemoSen↓, 1,   ChemoSen↑, 4,   Dose↓, 2,   Dose↝, 8,   Dose∅, 3,   eff↑, 6,   eff↝, 1,   RadioS↑, 1,   selectivity?, 1,  

Clinical Biomarkers(tgid=22)

ALC↓, 1,   BMD↑, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,   CardioT↓, 1,   ChemoSideEff↓, 1,   cognitive↑, 1,   neuroP↑, 1,   NP/CIPN↑, 1,   OS↑, 9,   QoL↑, 1,   radioP↑, 2,   Remission↑, 25,   Risk↓, 1,   toxicity↓, 6,   toxicity↑, 1,   toxicity↝, 1,   TumVol↓, 3,   Weight↑, 1,  

Infection & Microbiome(tgid=24)

CD8+↑, 1,  
Total Targets: 82

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

GSH↑, 1,   NRF2↑, 1,   ROS↓, 2,  

Drug Metabolism & Resistance(tgid=21)

BioAv↑, 1,   Half-Life↓, 1,  

Functional Outcomes(tgid=23)

toxicity∅, 1,  
Total Targets: 6

Scientific Paper Hit Count for: Remission, Remission
4 EGCG (Epigallocatechin Gallate)
3 Melatonin
2 Dichloroacetate
2 Vitamin C (Ascorbic Acid)
1 3-bromopyruvate
1 Silver-NanoParticles
1 Arsenic trioxide
1 Atorvastatin
1 Bicalutamide
1 Disulfiram
1 Copper and Cu NanoParticles
1 Zinc
1 Mushroom Chaga
1 Mushroom Reishi
1 Vitamin K2
1 Curcumin
1 Electrical Pulses
1 Exercise
1 Germanium
1 hydroxychloroquine
1 Chemotherapy
1 metronomic chemo
1 Bicarbonate(Sodium)
1 Sulforaphane (mainly Broccoli)
1 doxorubicin
1 Shikonin
1 Transarterial Chemoembolization
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:810  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page